6 Results for "

hyperlipoproteinemia

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "hyperlipoproteinemia" in MCE Product Catalog:

Cat. No.: HY-127055
CAS No.: 6964-20-1
Target:  

Apolipoprotein

Research Areas:  

Metabolic Disease

Tiadenol is an orally effective lipid-lowering compound and peroxisome proliferator. Tiadenol promotes peroxisome-associated fatty acid metabolism, and its induction of the activities of enzymes such as palmitoyl-CoA hydrolase, carnitine acetyl-transferase and catalase is mainly associated with de novo protein synthesis. The triglyceride-lowering effect of Tiadenol is not accompanied by increased activities of lipoprotein lipase (LPL) and hepatic lipase (HL), and it reduces VLDL Apo E. Tiadenol can be used in studies related to lipid metabolism, peroxisome proliferation and hyperlipoproteinemia .
loading...
    loading...
Cat. No.: HY-106581
CAS No.: 55285-45-5
Synonyms: EL-466
Target:  

Apolipoprotein

Research Areas:  

Metabolic Disease

Pirifibrate (EL-466) is a lipid-lowering compound. Pirifibrate slightly increases α-lipoprotein levels. Pirifibrate can be used for the research of type IIa, IIb and IV hyperlipoproteinemia .
loading...
    loading...
Cat. No.: HY-111983
CAS No.: 17365-01-4
Synonyms: CG-635
Etiroxate (CG-635) is a lipid lowing compound which can be used for hyperlipoproteinemia research .
loading...
    loading...
Cat. No.: HY-121583
CAS No.: 35449-36-6
Target:  

Drug Intermediate

Research Areas:  

Metabolic Disease

Gemcadiol is a potent antilipemic agent. Gemcadiol has the potential for the research of hyperlipoproteinemia .
loading...
    loading...
Cat. No.: HY-130587
CAS No.: 57775-27-6
Synonyms: Piperazine sultosylate; A-585
Target:  

LDLR Apolipoprotein

Research Areas:  

Metabolic Disease

Sultosilic acid piperazine salt (Piperazine sultosylate; A-585) is a lipid-lowering agent. Sultosilic acid piperazine salt modifies the blood lipids levels, reduces platelet adhesiveness without promoting peroxisomal activity of hepatocytes or producing other adverse side-effects .
loading...
    loading...
Cat. No.: HY-130053
CAS No.: 3771-19-5
Synonyms: SU-13-437
Target:  

Endogenous Metabolite

Research Areas:  

Cancer

Nafenopin (SU-13-437) is a peroxidase proliferator with liver tumor promoting activity. Nafenopin is also used as an anti-hyperlipoproteinemia compound. Nafenopin is able to induce oxidative stress in vivo, showing its effects on the liver. The mechanism of action of nafenopin has differentiated features compared to other non-genotoxic carcinogens .
loading...
    loading...